Dupilumab treatment increases transitional B cells in severe asthma

Allergy. 2023 Jul;78(7):2055-2057. doi: 10.1111/all.15703. Epub 2023 Mar 16.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Asthmatic Agents* / pharmacology
  • Anti-Asthmatic Agents* / therapeutic use
  • Antibodies, Monoclonal, Humanized / pharmacology
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma* / drug therapy
  • Humans
  • Precursor Cells, B-Lymphoid

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized
  • Anti-Asthmatic Agents